Ion channels have long been recognized as crucial modulators of cellular excitability and signaling, making them prime candidates for targeted drug development. However, the landscape of ion channel pharmacology has been hindered by challenges related to the structural complexity of binding sites, many of which are lipid-occupied, expansive, and planar, complicating the design of small molecules that can selectively modulate channel function without off-target effects. This is especially true for the transient receptor potential canonical 5 (TRPC5) channel, predominantly expressed in the brain and implicated in mood regulation.

Researchers have now employed a structure-guided macrocyclization approach to surmount these obstacles, effectively harnessing recent advances in cryo-electron microscopy (cryo-EM) to resolve high-resolution structures of TRPC5 in complex with novel ligands. The resultant macrocyclic compounds, particularly one designated JDIC-127, exhibit picomolar-level inhibitory activity with an IC50 of 374 picomolar, a staggering 200-fold improvement in potency compared to the benchmark inhibitor HC-070. This degree of potency heralds a new era of ion channel modulation, wherein minute concentrations of drug candidates can achieve highly selective inhibition, potentially minimizing side effects.

Macrocyclic structures confer unique advantages in drug design by constraining the conformational flexibility of ligands, thus enhancing binding affinity and specificity. JDIC-127’s macrocycle stabilizes its active conformation, facilitating precise interactions within the lipid-rich binding pocket of TRPC5. Notably, these interactions predominantly involve unique residues lining the S5 and S6 helices of the channel, a critical region contributing to gating and ion permeability. Such targeted engagement underpins the compound’s exceptional selectivity, drastically reducing cross-reactivity with homologous TRPC isoforms and other ion channels.

The elucidation of these binding interactions was achieved through an integrative approach, combining high-resolution cryo-EM data with advanced computational modeling. This synergy enabled the rational design of macrocycles tailored to exploit subtle structural distinctions within the TRPC5 lipid-binding domain. The methodology surmounts the traditional barrier posed by broad, flat, lipid-occupied sites that resist classical small-molecule binding modalities, thereby opening new avenues in ion channel pharmacology.

Beyond the biochemical and structural facets, JDIC-127 has demonstrated robust preclinical efficacy, aligning with its biochemical profile. Animal models of depression and anxiety exhibit amelioration of symptoms upon administration, suggesting that selective TRPC5 inhibition can modulate neurophysiological pathways underpinning these complex disorders. These findings invigorate the therapeutic potential of TRPC5-targeted agents and present JDIC-127 as a valuable pharmacological tool for dissecting TRPC5’s role in the central nervous system.

This research epitomizes the potential of macrocyclization as a transformative strategy in drug discovery for challenging targets. Unlike conventional linear molecules, macrocycles can effectively occupy and stabilize conformations within lipid-interacting domains, a feature previously difficult to exploit pharmacologically. Consequently, the study offers a conceptual and practical framework for extending this design paradigm towards other members of the TRP channel family and beyond, potentially addressing a spectrum of disease states linked to ion channel dysfunction.

Furthermore, the study underscores the critical integration of structure-based drug design with cutting-edge experimental approaches like cryo-EM, which has revolutionized our understanding of membrane protein pharmacology. The detailed structural insights into TRPC5-ligand complexes provide a template for iterative refinement, improving drug-like properties and enabling precision medicine approaches in neuropsychiatric therapeutics.

Importantly, the selective inhibition profile demonstrated by JDIC-127 mitigates concerns related to off-target ion channel modulation, a common hurdle in developing central nervous system drugs. This selective engagement minimizes perturbation of physiological ion currents mediated by related channels, thereby reducing adverse effects and enhancing clinical translatability.

The implications of this work extend beyond academic inquiry, signaling a promising trajectory for pharmaceutical development focused on TRP channels—known to be involved in diverse physiological processes including sensation, vasoregulation, and metabolic regulation. By paving the way for the rational design of selective macrocyclic inhibitors, this research bolsters the pipeline for innovative drugs addressing not only neuropsychiatric conditions but potentially cardiovascular and metabolic diseases as well.

In sum, the reported structure-guided design and functional validation of JDIC-127 epitomize a milestone in ion channel drug discovery. By exploiting the conformational rigidity and enhanced binding kinetics conferred by macrocycles, combined with precise structural characterization, this study offers a blueprint for overcoming long-standing challenges associated with lipid-occupied channels and achieving therapeutically viable selectivity and potency.

As this research progresses towards clinical validation, it heralds a new class of molecular tools with the capacity to modulate neuronal excitability with unprecedented precision. The promise of JDIC-127 extends to refining our understanding of TRPC5’s physiological roles and providing a foundation for developing efficacious antidepressant and anxiolytic treatments, with broader implications across neuropharmacology and medicinal chemistry.

Subject of Research: Structure-guided drug design of highly selective macrocyclic inhibitors targeting the TRPC5 ion channel for antidepressant therapy.

Article Title: Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity.

News Publication Date: 2026 (exact date not specified).

Web References: DOI link – http://dx.doi.org/10.1016/j.apsb.2025.10.028

Keywords: TRPC5, Ion channel, Structure-based drug design, Macrocyclization, Selectivity, Cryo-EM, Antidepressant, Anxiolytic

The medial prefrontal cortex, a critical region nestled in the frontal lobes of the brain, has long been recognized for its role in personality, decision-making, and emotional regulation. Despite decades of research, the exact circuitry by which this brain region integrates myriad sensory inputs with internal physiological states to produce adaptive or maladaptive behavioral responses remained elusive. The UCLA team employed cutting-edge techniques—combining genetic labeling strategies, high-resolution 3D brain imaging, and artificial intelligence-driven circuit mapping—to dissect the fine-scale connectivity and organization of mouse mPFC subregions, specifically the dorsal peduncular area (DP) and infralimbic area (ILA).

Employing genetically encoded tracers, the researchers traced neuronal projections and synaptic partners within the mPFC, constructing a detailed wiring diagram of these visceromotor hubs. These areas act as integrative nodes, synthesizing information related to external sensory stimuli and internal bodily signals, such as those from the autonomic nervous system, to coordinate behavioral and physiological responses to stress. The sophisticated AI tools developed for this study enabled the automated reconstruction of neuronal circuits in three dimensions, revealing previously unseen patterns of connectivity and interregional communication.

One of the most compelling insights from this work concerns how these mPFC hubs not only modulate emotional reactivity but maintain emotional stability through balanced excitatory and inhibitory circuits. Dysregulations in this delicate balance could underlie the emotional instability observed in myriad psychiatric disorders. By elucidating the precise synaptic arrangements and molecular identities of these neurons, the study provides a cellular-level blueprint that parallels similar visceromotor circuits conserved in the human ventromedial prefrontal cortex (vmPFC).

The implications of these findings echo a historical neuroscience narrative dating back over 170 years to the famous case of Phineas Gage, a railroad worker who survived a traumatic frontal lobe injury yet underwent profound personality changes. Gage’s case underscored the significance of the prefrontal cortex in governing social behavior and emotional regulation. However, the neural underpinnings of such personality alterations have long remained a mystery. This research takes a pivotal step toward filling that knowledge gap and directly links mPFC circuitry to the regulation of complex behaviors and stress responses.

Moreover, the study’s integration of advanced 3D reconstructions with AI-driven analysis sets a new standard for investigating brain architecture at the mesoscale level. This methodological breakthrough not only accelerates data acquisition and analysis but also enhances reproducibility, offering an unprecedented resolution for mapping brain circuits involved in neuropsychiatric disorder pathophysiology.

Beyond the fundamental scientific advancements, this work holds profound clinical relevance. By pinpointing the neuronal circuits that orchestrate physiological and emotional responses to stress, the UCLA team offers promising targets for the development of novel, precision-based therapeutic interventions. These may one day include targeted neuromodulation, pharmacological agents aimed at circuit-specific molecular markers, and improved diagnostic tools capable of identifying early signs of neuropsychiatric dysfunction.

Additionally, the study raises intriguing questions about the interaction between brain regions responsible for integrating internal bodily states and those processing external environmental information. Understanding how these networks synchronize to generate coherent behavior under stress has enormous implications for tackling disorders characterized by impaired emotional regulation and social cognition.

The researchers underscore that the cellular and circuit-level insights gained from mice are highly relevant to human brain function due to evolutionary conservation of mPFC structures and connectivity patterns. This conservation bolsters the translational potential of the findings, suggesting that future therapies targeting homologous human brain circuits could mitigate the debilitating effects of mood and anxiety disorders.

Furthermore, this research exemplifies how multidisciplinary approaches—bridging genetics, neuroanatomy, computational modeling, and behavioral neuroscience—can unravel the complexities of brain function. Such holistic perspectives are vital for deciphering the labyrinth of neural interactions that underlie human cognition, emotion, and behavior.

In summary, the UCLA-led study provides a seminal contribution to neuroscience by delivering a comprehensive, high-resolution map of the mouse medial prefrontal cortex’s visceromotor circuits. This work not only enriches our fundamental understanding of emotional and stress regulation but also charts a course toward innovative interventions addressing some of the most pressing challenges in mental health today. As Dr. Hong Wei Dong, the study’s lead author and director of the UCLA Brain Research & Artificial Intelligence Nexus, eloquently stated, this is “a wiring diagram of one of the brain’s most mysterious control centers,” opening the floodgates to targeted therapies for stress-related and social dysfunction disorders.

Subject of Research: Animals
Article Title: Neural networks of the mouse visceromotor cortex
News Publication Date: 27-Aug-2025
Web References: https://www.nature.com/articles/s41586-025-09360-w, http://dx.doi.org/10.1038/s41586-025-09360-w
References: Dong, H.W., et al. (2025). Neural networks of the mouse visceromotor cortex. Nature. DOI: 10.1038/s41586-025-09360-w
Keywords: Behavioral neuroscience, Psychiatry, Mental health, Psychiatric disorders, Neuroscience, Anxiety disorders, Behavior disorders

The ATP-binding cassette (ABC) transporters represent a large family of proteins responsible for translocating various substrates across cellular membranes utilizing ATP hydrolysis. Abcc5/MRP5, expressed abundantly in neural tissue, had long been hypothesized to contribute primarily to the efflux of organic anions and nucleoside analogues. However, the recent data suggest that its functional repertoire extends into realms crucial for neuronal communication and plasticity. This paradigm shift underscores the interconnectedness of membrane transport mechanisms with synaptic physiology and behavioral outputs.

Central to the study’s narrative is memory consolidation, the fundamental process by which transient experiences are forged into long-lasting memories. Through a combination of genetic, electrophysiological, and behavioral assays performed on murine models deficient in Abcc5, the research team demonstrated clear impairments in both short- and long-term memory paradigms. Intriguingly, these deficits correlated not only with altered neurotransmitter dynamics but also with disruption in gene expression patterns associated with synaptic remodeling. This implicates Abcc5 as a critical integrator of signaling events necessary for the stabilization of memory engrams.

Circadian rhythms, the endogenous oscillations governing physiological and behavioral cycles, are finely tuned by a network of molecular clocks and environmental cues. The study uncovered a hitherto unrecognized role for Abcc5 in the regulation of these rhythms. Mice bearing targeted deletions of Abcc5 exhibited aberrant locomotor activity patterns, desynchronization of core clock gene expression in the suprachiasmatic nucleus, and altered melatonin secretion profiles. These findings highlight that beyond its transporter function, Abcc5 may modulate circadian homeostasis by influencing signaling pathways linked to neuronal excitability and rhythmic gene transcription.

Glutamatergic neurotransmission, mediated primarily by the excitatory neurotransmitter glutamate, forms the backbone of synaptic communication in the central nervous system. Banks and colleagues provided compelling evidence that Abcc5 regulates aspects of glutamate signaling, notably through its impact on glutamate receptor trafficking and synaptic vesicle cycling. Electrophysiological recordings revealed diminished excitatory postsynaptic potentials and impaired long-term potentiation (LTP) in hippocampal slices derived from Abcc5 knockout animals. These functional impairments dovetail with the cognitive deficits observed in vivo, reinforcing the transporter’s role in sustaining synaptic plasticity.

Delving into the molecular underpinnings, the researchers employed advanced proteomic analyses and identified disrupted clustering of NMDA and AMPA receptor subunits in the absence of Abcc5. Such alterations compromise synaptic strength and adaptability, integral components of memory encoding processes. Moreover, the team observed altered levels of intracellular signaling molecules such as CaMKII and CREB, which are well-established mediators of activity-dependent gene expression pertinent to learning and memory.

The link between Abcc5 function and circadian signaling was further explored through transcriptomic profiling, which revealed misexpression of clock genes including Per1, Cry1, and Bmal1. These deviations suggest that Abcc5 might be necessary for the precise temporal control of gene expression cycles that orchestrate physiological rhythms. Additionally, altered redox states and ATP availability observed in mutant mice point towards a metabolic dimension to Abcc5’s regulatory role, integrating energy dynamics with circadian biochemical cascades.

Of particular significance is the potential translational implication of these findings. Disruptions in memory consolidation and circadian dysregulation are hallmark features of numerous neuropsychiatric conditions such as Alzheimer’s disease, schizophrenia, and mood disorders. By identifying Abcc5 as a nodal point connecting these processes, the study beckons the development of pharmacological modulators aimed at optimizing transporter activity. Such interventions could restore synaptic efficacy and stabilize biological rhythms, offering multifactorial remediation for cognitive and affective symptoms.

The research also opens exciting avenues for the study of drug resistance phenomena in psychiatric treatment. Given that ABC transporters are known to influence the pharmacokinetics of many neuroactive compounds, Abcc5 might serve as a bridge linking membrane transporter function with therapeutic outcomes. Understanding this relationship could refine dosing protocols and improve the efficacy of existing medications targeting glutamatergic pathways or circadian regulators.

Methodologically, the study’s strength lies in its integrative approach, combining in vivo behavioral assessments with exhaustive molecular characterizations. Techniques such as in situ hybridization, high-resolution microscopy, and patch-clamp electrophysiology provided a comprehensive picture of how genetic ablation of Abcc5 culminates in altered neuronal circuits and behavioral phenotypes. This multi-tiered strategy established causal links rather than mere associations, strengthening the validity of the conclusions drawn.

Furthermore, the work contributes novel insights into the intracellular trafficking roles played by ABC transporters in neurons, a comparatively underexplored aspect of their function. The authors propose a model whereby Abcc5 participates in the recycling and surface expression of key synaptic proteins, potentially influencing receptor availability and synaptic strength. This mechanistic framework invites broader examination across other members of the ABC transporter family and their involvement in neural dynamics.

Notably, the discoveries elucidate how peripheral and central functions of transporters such as Abcc5 are intertwined. While traditionally associated with xenobiotic clearance and cellular protection, this study places Abcc5 squarely in the domain of neurophysiology, underscoring the protein’s dualistic nature. Understanding these diverse roles will be critical as the field moves toward precision medicine approaches in neurology and psychiatry.

The implications for circadian biology are equally profound. As global lifestyles increasingly encroach upon natural rhythms, understanding molecular players like Abcc5 that govern the internal clock becomes ever more pressing. The transporter’s influence on rhythmic gene expression and behavioral patterns suggests it might also mediate the impact of environmental stressors on circadian stability, providing a molecular target for interventions aimed at circadian misalignment.

In conclusion, the work by Banks et al. presents a compelling narrative that redefines the functional landscape of the Abcc5 ATP-binding cassette transporter within the mammalian brain. By bridging the realms of memory, circadian biology, and synaptic signaling, these findings propel Abcc5 from a peripheral actor to a central orchestrator of neural health and behavior. Future research focused on this transporter could unveil transformative strategies to combat cognitive decline and circadian disturbances associated with neuropsychiatric illnesses, heralding a new era in brain therapeutics.

Subject of Research: The role of the murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) in memory consolidation, circadian rhythm regulation, and glutamatergic signaling.

Article Title: The murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) plays a role in memory consolidation, circadian rhythm regulation and glutamatergic signalling.

Article References: Banks, G., Cyranka, M., Vedovato, N. et al. The murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) plays a role in memory consolidation, circadian rhythm regulation and glutamatergic signalling. Transl Psychiatry 15, 218 (2025). https://doi.org/10.1038/s41398-025-03438-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03438-9